Canada markets closed

Equillium, Inc. (0FY.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6285+0.0210 (+3.46%)
At close: 09:15AM CET
Full screen
Previous Close0.6075
Open0.6285
Bid0.5870 x 0
Ask0.6100 x 0
Day's Range0.6285 - 0.6285
52 Week Range0.6075 - 3.0400
Volume1,000
Avg. Volume68
Market Cap21.629M
Beta (5Y Monthly)1.24
PE Ratio (TTM)N/A
EPS (TTM)-1.8600
Earnings DateMar 22, 2023 - Mar 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • Business Wire

    Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference

    LA JOLLA, Calif., March 22, 2023--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference.

  • Business Wire

    Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR

    LA JOLLA, Calif., February 17, 2023--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that an oral presentation was given yesterday afternoon at the Tandem Meetings of the American Society of Transplantation and Cellular Therapy, and the Center for International Blood & Marrow Transplant Research.

  • Business Wire

    Equillium to Present at the SVB Securities Annual Global Healthcare Conference

    LA JOLLA, Calif., February 07, 2023--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will present at the SVB Securities Annual Global Biopharma Conference.